Xencor reported $0.5 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 0.50 -0.78 -0.08 Nov/04
FY2026Q2 Jun/2026 -0.29 -0.80 -0.41 Aug/05
FY2026Q1 Mar/2026 -1.71 -0.66 -0.66 May/06
FY2025Q4 Dec/2025 -0.09 -0.6 -0.62 Feb/25
FY2025Q3 Sep/2025 -0.08 -0.69 -0.71 Nov/05




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
Arrowhead Research USD -5.11 3.75 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Cytokinetics USD -1.37 0.13 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
MacroGenics USD 0.31 0.89 Jun/2026
Merck USD 2.49 2.62 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Xencor USD 0.5 0.79 Sep/2026